Empagliflozin/metformin/sitagliptinEuglycemic diabetic ketoacidosis secondary to pharmacodynamic drug-drug interaction: case report

被引：0

作者：

机构：

来源：

Reactions Weekly | 2024年 / 2039卷 / 1期

关键词：

D O I：

10.1007/s40278-024-72641-9

中图分类号：

学科分类号：

摘要：

引用

页码：204 / 204

共 50 条

[31] Empagliflozin/methylprednisoloneVarious toxicities and drug interaction: case report
Reactions Weekly, 2022, 1934 (1) : 179 - 179
[32] Multiple drugsVarious toxicities and drug-drug interaction: case report
Reactions Weekly, 2024, 2025 (1) : 344 - 344
[33] Managing the Drug-Drug Interaction With Apixaban and Primidone: A Case Report
Manis, Melanie M.
Petersen, Kat
Roberts, Megan Z.
Kyle, Jeffrey A.
HOSPITAL PHARMACY, 2023, 58 (04) : 345 - 349
[34] Mercaptopurine/TirzepatideHepatotoxicity following drug-drug interaction: case report
Reactions Weekly, 2024, 2039 (1) : 313 - 313
[35] Amoxicillin/clarithromycinManic episode following pharmacodynamic drug-drug interaction
Reactions Weekly, 2024, 2001 (1) : 20 - 20
[36] Phantom Lactic Acidosis Secondary to a Drug-Drug Interaction between Ribociclib and Metformin in the Setting of CKD
Maryam, Bibi
Diaz-Barba, Adolfo
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2024, 35 (10):
[37] Empagliflozin/metforminEuglycaemic diabetic-ketoacidosis: case report
Reactions Weekly, 2022, 1908 (1) : 246 - 246
[38] Empagliflozin/insulinEuglycaemic diabetic ketoacidosis and hypophosphataemia: case report
Reactions Weekly, 2021, 1869 (1) : 147 - 147
[39] Antidepressants/propofol/valproic-acidParalysis with anaesthesia awareness with recall following pharmacodynamic drug-drug interaction: case report
Reactions Weekly, 2023, 1971 (1) : 29 - 29
[40] Tolvaptan/warfarinIncreased prothrombin time-international normalised ratio following drug-drug pharmacodynamic interaction: case report
Reactions Weekly, 2022, 1908 (1) : 525 - 525

← 1 2 3 4 5 →